Three major figures at Big Pharma firm Moderna have made their way onto the prestigious Forbes 400 list, after raking in billions in Covid-19 vaccine sales to governments amid the global pandemic.

Two founding members and a top investor at the company cracked into the catalogue of American affluence this week. The list charts the 400 richest citizens by net worth, and now includes Moderna’s chairman and co-founder, Noubar Afeyan, another co-founder, Robert Langer, as well as Timothy Springer, among the firm’s earliest investors. All three reportedly boast net worths of at least $3.5 billion each.

While all three remain far below the headliners on the 400 list – among them Jeff Bezos, Mark Zuckerberg, and Elon Musk – they were propelled onto the catalogue thanks to the massive global vaccination campaign against Covid-19, which has seen Moderna transact with governments around the world and pull in billions of dollars ultimately sourced from taxpayers. 

Springer ranked the highest out of the three, taking the 176th slot with a net worth of $5.9 billion. Ageyan followed, boasting $5 billion net in the 212th space, while Langer lagged just behind at $4.9 billion, placing 10 spaces lower at 222nd.

The Moderna personnel cracked the list just as former US President Donald Trump lost his place this week, though the ex-president reportedly remains a billionaire.

Read More: 9 new Big Pharma billionaires emerge amid Covid-19 vaccine rollout